National Comprehensive Cancer Network

|
|
|
|
For Patients

About NCCN

Esophageal/Gastric Cancers Panel

View NCCN Management Team Disclosures | View NCCN Guidelines Staff Disclosures | View NCCN ORP Staff Disclosures

Panel Member Clinical Research Support Advisory Boards, Speakers Bureau, Expert Witness, or Consultant Patent, Equity, or Royalty Other Date Completed

Jaffer A. Ajani, MD

Bayer HealthCare;
ImClone Systems Incorporated;
Ascenta;
Genta;
sanofi-aventis U.S.;
Taiho Parmaceuticals Co., Ltd.

Bristol-Myers Squibb Company;
sanofi-aventis U.S.

None

None

8/5/2009

James S. Barthel, MD

CSA, Inc.

None

None

None

11/20/2009

Tanios Bekaii-Saab, MD

Genentech, Inc.;
National Cancer Institute;
Pfizer Inc.;
Roche Laboratories, Inc.

Genentech, Inc.;
sanofi-aventis U.S.

None

None

10/21/2009

David J. Bentrem, MD

None

None

None

None

7/1/2009

Thomas A. D'Amico, MD

None

Covidien AG;
Scanlan

None

None

7/1/2009

Prajnan Das, MD, MS, MPH

None

None

None

None

7/8/2009

Crystal S. Denlinger, MD

None

None

None

None

7/8/2009

Charles S. Fuchs, MD, MPH

Amgen Inc.;
AstraZeneca Pharmaceuticals LP;
Genentech, Inc.;
ImClone Systems Incorporated;
Roche Laboratories, Inc.

AstraZeneca Pharmaceuticals LP;
Genentech, Inc.;
Roche Laboratories, Inc.

None

None

11/19/2009

Lauren Gallagher, PhD

None

None

None

None

8/28/2009

Hans Gerdes, MD

None

None

None

None

10/6/2009

Kristina M Gregory, RN, MSN, OCN

None

None

None

None

8/21/2009

James A. Hayman, MD, MBA

None

None

None

None

10/6/2009

Lisa Hazard, MD

None

None

None

None

9/28/2009

Wayne L Hofstetter, MD

None

None

None

None

7/1/2009

David H. Ilson, MD, PhD

Bayer HealthCare;
Bristol-Myers Squibb Company;
Genentech, Inc.;
sanofi-aventis U.S.

Genentech, Inc.;
sanofi-aventis U.S.

None

None

11/19/2009

Rajesh N. Keswani, MD

None

None

None

None

11/20/2009

Lawrence R. Kleinberg, MD

None

None

None

None

1/9/2009

Michael Korn, MD

None

None

None

None

11/3/2009

Joan S McClure, MS

None

None

None

None

9/28/2009

Nicole McMillian, MS

None

None

None

None

7/21/2009

Mary F. Mulcahy, MD

sanofi-aventis U.S.

None

None

None

11/17/2009

Mark B. Orringer, MD

None

None

None

None

9/28/2009

Raymond U. Osarogiagbon, MD, FACP

Bristol-Myers Squibb Company;
Eli Lilly and Company;
OSI Pharmaceuticals, Inc.;
sanofi-aventis U.S.

Genentech, Inc.;
OSI Pharmaceuticals, Inc.;
sanofi-aventis U.S.;
UnitedHealthcare

None

None

10/1/2009

James A. Posey, MD

Bayer HealthCare

Bayer HealthCare

None

None

11/19/2009

Aaron R. Sasson, MD

None

None

None

None

11/19/2009

Walter J. Scott, MD, FACS

None

None

None

None

11/19/2009

Stephen Shibata, MD

None

Genentech, Inc.;
sanofi-aventis U.S.

None

None

9/28/2009

Vivian E. M. Strong, MD

None

None

None

None

10/2/2009

Hema Sundar, PhD

None

None

None

Cephalon, Inc.

12/15/2008

Mary Kay Washington, MD, PhD

None

None

None

None

9/28/2009

Christopher Willett, MD

None

None

None

None

11/17/2009

Douglas E. Wood, MD

None

None

None

None

9/28/2009

Cameron D. Wright, MD

None

None

None

None

7/6/2009

Gary Yang, MD

None

None

None

None

7/2/2009

 

NCCN Website Supporters

Privacy Policy| Disclaimer| Site Map| Contact Us| Help| Copyright 2009